Ann Surg Oncol
- CHUNG AP, Dang CM, Karlan SR, Amersi FF, et al
ASO Visual Abstract: A Prospective Study of Sentinel Node Biopsy Omission
in Women Age >/= 65 with ER+ Breast Cancer.
Ann Surg Oncol. 2024 Mar 6. doi: 10.1245/s10434-024-15137.
- QIU M, Liang F, Xie Y, Yang H, et al
Clinical Outcomes of Transaxillary Reverse-Sequence Endoscopic Nipple-Sparing
Mastectomy and Direct-to-Implant Prepectoral Breast Reconstruction: A Prospective
Study of Initial 68 Procedures.
Ann Surg Oncol. 2024;31:2777-2785.
- WESTENEND P, Meurs C, van Bekkum S, van Rosmalen J, et al
ASO Author Reflections: What Can Prediction Models for Upstaging of DCIS
Diagnosed on Biopsy Tell Us About DCIS Surveillance Trials?
Ann Surg Oncol. 2024;31:2272-2273.
- EVERIDGE SA, Sun J, Teshome M, Tamirisa N, et al
ASO Visual Abstract: Lobular Neoplasia Diagnosed by MRI-Guided Breast
Biopsy-Identifying Upgrade Rate to Malignancy and Outcomes of Clinical and
Surgical Management.
Ann Surg Oncol. 2024;31:2276-2277.
- SINGH P, Agnese D, Amin M, Barrio AV, et al
Society of Surgical Oncology Breast Disease Site Working Group Statement on
Contralateral Mastectomy: Indications, Outcomes, and Risks.
Ann Surg Oncol. 2024;31:2212-2223.
- RUBENSTEIN RN, Kim M, Plotsker EL, Chu JJ, et al
Early Complications in Prepectoral Tissue Expander-Based Breast Reconstruction.
Ann Surg Oncol. 2024;31:2766-2776.
- QIU M, Liang F, Xie Y, Yang H, et al
ASO Author Reflections: A Novel Technique of Transaxillary Reverse-Sequence
Endoscopic Nipple-Sparing Mastectomy and Direct-to-Implant Prepectoral Breast
Reconstruction.
Ann Surg Oncol. 2024;31:2791-2792.
- POLIDORIO N, Montagna G, Sevilimedu V, Le T, et al
Do HER2-Low Tumors Have a Distinct Clinicopathologic Phenotype?
Ann Surg Oncol. 2024;31:2231-2243.
- QIU M, Liang F, Xie Y, Yang H, et al
ASO Visual Abstract: Clinical Outcomes of Transaxillary Reverse-Sequence
Endoscopic Nipple-Sparing Mastectomy and Direct-to-Implant Prepectoral Breast
Reconstruction-A Prospective Study of Initial 68 Procedures.
Ann Surg Oncol. 2024;31:2794-2795.
- EVERIDGE SA, Sun J, Teshome M, Tamirisa N, et al
Lobular Neoplasia Diagnosed by MRI-Guided Breast Biopsy: Identifying Upgrade Rate
to Malignancy and Outcomes of Clinical and Surgical Management.
Ann Surg Oncol. 2024;31:2224-2230.
BMC Cancer
- SHITRIT IB, Wang A, Ilan K, Agassi R, et al
Epidemiological, clinical, and pathological characteristics of invasive breast
cancer in Bedouin and Jewish women in southern Israel: a retrospective
comparative study.
BMC Cancer. 2024;24:310.
- KHANNA D, Sharma P, Budukh A, Vishwakarma R, et al
Rural-urban disparity in cancer burden and care: findings from an Indian cancer
registry.
BMC Cancer. 2024;24:308.
- GOH SP, Ong SC, Chan JE
Economic evaluation of germline genetic testing for breast cancer in low- and
middle-income countries: a systematic review.
BMC Cancer. 2024;24:316.
- KANG D, Wang C, Han Z, Zheng L, et al
Exploration of the relationship between tumor-infiltrating lymphocyte score and
histological grade in breast cancer.
BMC Cancer. 2024;24:318.
- MOLIERE S, Lodi M, Leblanc S, Gressel A, et al
MMP-11 expression in early luminal breast cancer: associations with clinical,
MRI, pathological characteristics, and disease-free survival.
BMC Cancer. 2024;24:295.
- MESHKANI Z, Moradi N, Aboutorabi A, Farabi H, et al
A cost-benefit analysis of genetic screening test for breast cancer in Iran.
BMC Cancer. 2024;24:279.
- REN J, Chen W, Zhou Y, Sun J, et al
The novel circRNA circ_0045881 inhibits cell proliferation and invasion by
targeting mir-214-3p in triple-negative breast cancer.
BMC Cancer. 2024;24:278.
Breast Cancer
- HATTORI M, Honma N, Nagai S, Narui K, et al
Trastuzumab deruxtecan for human epidermal growth factor receptor 2-low advanced
or metastatic breast cancer: recommendations from the Japanese Breast Cancer
Society Clinical Practice Guidelines.
Breast Cancer. 2024 Mar 4. doi: 10.1007/s12282-024-01550.
- OBA K, Adachi M, Kobayashi T, Takaya E, et al
Deep learning model to predict Ki-67 expression of breast cancer using digital
breast tomosynthesis.
Breast Cancer. 2024 Mar 7. doi: 10.1007/s12282-024-01549.
- KIDA K, Yamada A, Shimada K, Narui K, et al
A prospective comparison study utilizing patient-reported outcomes of
taxane-related peripheral neuropathy between nab-paclitaxel and standard
paclitaxel in patients with breast cancer.
Breast Cancer. 2024 Mar 8. doi: 10.1007/s12282-024-01551.
Breast Cancer (Dove Med Press)
- MONTEIRO MR, Nunes NCC, Junior AADS, Fede ABS, et al
Antibody-Drug Conjugates in Breast Cancer: A Comprehensive Review of How to
Selectively Deliver Payloads.
Breast Cancer (Dove Med Press). 2024;16:51-70.
Breast Cancer Res
- CASTRESANA-AGUIRRE M, Johansson A, Matikas A, Foukakis T, et al
Clinically relevant gene signatures provide independent prognostic information in
older breast cancer patients.
Breast Cancer Res. 2024;26:38.
- HAN Y, Otegbeye EE, Stoll C, Hardi A, et al
How does weight gain since the age of 18 years affect breast cancer risk in later
life? A meta-analysis.
Breast Cancer Res. 2024;26:39.
- RODON J, Demanse D, Rugo HS, Burris HA, et al
A risk analysis of alpelisib-induced hyperglycemia in patients with advanced
solid tumors and breast cancer.
Breast Cancer Res. 2024;26:36.
- SMOOTS SG, Schreiber AR, Jackson MM, Bagby SM, et al
Overcoming doxorubicin resistance in triple-negative breast cancer using the
class I-targeting HDAC inhibitor bocodepsin/OKI-179 to promote apoptosis.
Breast Cancer Res. 2024;26:35.
Breast Cancer Res Treat
- KULOTHUNGAN V, Ramamoorthy T, Sathishkumar K, Mohan R, et al
Burden of female breast cancer in India: estimates of YLDs, YLLs, and DALYs at
national and subnational levels based on the national cancer registry programme.
Breast Cancer Res Treat. 2024 Mar 4. doi: 10.1007/s10549-024-07264.
- PLICHTA JK, Thomas SM, Wang X, McDuff SGR, et al
Survival among patients with untreated metastatic breast cancer: "What if I do
nothing?".
Breast Cancer Res Treat. 2024 Mar 5. doi: 10.1007/s10549-024-07265.
- SUN H, Kang EY, Chen H, Sweeney KJ, et al
Immunohistochemical assessment of HER2 low breast cancer: interobserver
reproducibility and correlation with digital image analysis.
Breast Cancer Res Treat. 2024 Mar 5. doi: 10.1007/s10549-024-07256.
- CAMPBELL TM, Campbell EK, Culakova E, Blanchard LM, et al
A whole-food, plant-based randomized controlled trial in metastatic breast
cancer: weight, cardiometabolic, and hormonal outcomes.
Breast Cancer Res Treat. 2024 Mar 6. doi: 10.1007/s10549-024-07266.
- FINSTERBUSCH K, van Diest PJ, Focke CM
Intertumoral heterogeneity of bifocal breast cancer: a morphological and
molecular study.
Breast Cancer Res Treat. 2024 Mar 7. doi: 10.1007/s10549-024-07281.
- BAYRAKCEKEN E, Yarali S, Alkan O
Identify risk factors affecting participation of Turkish women in mammography
screening for breast cancer prevention.
Breast Cancer Res Treat. 2024 Mar 7. doi: 10.1007/s10549-024-07296.
- GARCIA-TORRALBA E, Perez Ramos M, Ivars Rubio A, Navarro Manzano E, et al
Deconstructing neutrophil to lymphocyte ratio (NLR) in early breast cancer: lack
of prognostic utility and biological correlates across tumor subtypes.
Breast Cancer Res Treat. 2024 Mar 7. doi: 10.1007/s10549-024-07286.
- AVILA J, Leone J, Vallejo CT, Lin NU, et al
Survival analysis of patients with brain metastases at initial breast cancer
diagnosis over the last decade.
Breast Cancer Res Treat. 2024 Mar 7. doi: 10.1007/s10549-024-07290.
- GION M, Garcia-Mosquera JJ, Perez-Garcia JM, Peg V, et al
Correlation between trophoblast cell-surface antigen-2 (Trop-2) expression and
pathological complete response in patients with HER2-positive early breast cancer
treated with neoadjuvant docetaxel, carboplatin, trastuzumab, and pertuzumab.
Breast Cancer Res Treat. 2024 Mar 8. doi: 10.1007/s10549-024-07292.
Breast J
- SUSINI P, Marcaccini G, Giardino FR, Pozzi M, et al
Selective Capsulotomies and Partial Capsulectomy in Implant-Based Breast
Reconstruction Revision Surgery.
Breast J. 2024;2024:9097040.
Cancer
- DELEIRE T, Mitchell JM, De La Cruz L, Isaacs C, et al
Nonclinical factors associated with the treatment of older women with newly
diagnosed low-grade ductal carcinoma in situ.
Cancer. 2024;130:1041-1051.
- NIERENGARTEN MB
Cardiotoxicity of breast cancer drugs requires additional monitoring.
Cancer. 2024;130:1013-1014.
- NIERENGARTEN MB
Routine estradiol testing recommended for women at high risk of breast cancer.
Cancer. 2024;130:1014.
Cancer Chemother Pharmacol
- YUCEL KB, Aydos U, Sutcuoglu O, Kilic ACK, et al
Visceral obesity and sarcopenia as predictors of efficacy and hematological
toxicity in patients with metastatic breast cancer treated with CDK 4/6
inhibitors.
Cancer Chemother Pharmacol. 2024 Mar 4. doi: 10.1007/s00280-024-04641.
- ZHENG W, Peng W, Qian F, Zhang M, et al
Vitamin D suppresses CD133+/CD44 + cancer stem cell stemness by inhibiting NF-kappaB
signaling and reducing NLRP3 expression in triple-negative breast cancer.
Cancer Chemother Pharmacol. 2024 Mar 8. doi: 10.1007/s00280-024-04660.
Cancer Epidemiol Biomarkers Prev
- LEE M, Kotake R, Yamauchi H
Physical Activity and Mammographic Density in Japanese Women.
Cancer Epidemiol Biomarkers Prev. 2024;33:365-370.
- SIEGEL SD, Zhang Y, Lynch SM, Rowland J, et al
A Novel Approach for Conducting a Catchment Area Analysis of Breast Cancer by Age
and Stage for a Community Cancer Center.
Cancer Epidemiol Biomarkers Prev. 2024 Mar 7. doi: 10.1158/1055-9965.EPI-23-1125
Cancer Lett
- WANG X, Deng X, Hu J, Zheng W, et al
K48-linked deubiquitination of VGLL4 by USP15 enhances the efficacy of tumor
immunotherapy in triple-negative breast cancer.
Cancer Lett. 2024 Feb 29:216764. doi: 10.1016/j.canlet.2024.216764.
Carcinogenesis
- KIM H, Son S, Ko Y, Lim H, et al
CYR61 confers chemoresistance by upregulating survivin expression in
triple-negative breast cancer.
Carcinogenesis. 2024 Mar 6:bgae013. doi: 10.1093.
Clin Breast Cancer
- LIAO M, Webster J, Coonrod EM, Weilbaecher KN, et al
BCAR4 Expression as a Predictive Biomarker for Endocrine Therapy Resistance in
Breast Cancer.
Clin Breast Cancer. 2024 Feb 16:S1526-8209(24)00047.
- MALHOTRA S, Tadros AB
New Strategies for Locally Advanced Breast Cancer: A Review of Inflammatory
Breast Cancer and Nonresponders.
Clin Breast Cancer. 2024 Jan 21:S1526-8209(24)00009.
Clin Med Insights Oncol
- AHMADI S, Surmava S, Kvaratskhelia D, Gogolashvili A, et al
Association Between Multiple Single Nucleotide Polymorphisms in Folate Metabolism
Pathway and Breast Cancer Risk in Georgian Women: A Case-Control Study.
Clin Med Insights Oncol. 2024;18:11795549241233693.
Discov Oncol
- VALIZADEH OSALO M, Hosseini P, Charkhian H, Soltanzadeh H, et al
The prevalence of ADSL (rs3788579) and CYP1A2 (rs17861162) polymorphisms in
female breast cancer patients in North-West Iran.
Discov Oncol. 2024;15:59.
Histopathology
- LY A, Garcia V, Blenman KRM, Ehinger A, et al
Training pathologists to assess stromal tumour-infiltrating lymphocytes in breast
cancer synergises efforts in clinical care and scientific research.
Histopathology. 2024 Mar 3. doi: 10.1111/his.15140.
- LI JJX, Ni SYB, Tsang JYS, Chan WY, et al
Neutrophil-lymphocyte ratio reflects tumour-infiltrating lymphocytes and
tumour-associated macrophages and independently predicts poor outcome in breast
cancers with neoadjuvant chemotherapy.
Histopathology. 2024;84:810-821.
- ALKHAYYAT R, Abbas A, Quinn CM, Rakha EA, et al
Tumour 63 protein (p63) in breast pathology: biology, immunohistochemistry,
diagnostic applications, and pitfalls.
Histopathology. 2024;84:723-741.
Int J Cancer
- LIU X, Xie X, Sui C, Liu X, et al
Unraveling the cross-talk between N6-methyladenosine modification and non-coding
RNAs in breast cancer: Mechanisms and clinical implications.
Int J Cancer. 2024 Mar 1. doi: 10.1002/ijc.34900.
- LUFTNER D, Schuetz F, Schneeweiss A, Hartkopf A, et al
Efficacy and safety of everolimus plus exemestane in patients with hormone
receptor-positive, HER-2-negative advanced breast cancer: Results from the
open-label, multicentre, non-interventional BRAWO study.
Int J Cancer. 2024 Mar 6. doi: 10.1002/ijc.34912.
Int J Oncol
- AI L, Yi N, Qiu C, Huang W, et al
Revolutionizing breast cancer treatment: Harnessing the related mechanisms and
drugs for regulated cell death (Review).
Int J Oncol. 2024;64:46.
Int J Radiat Oncol Biol Phys
- WU VS, Khlopin M, Chadha M, Smith-Graziani DJ, et al
Out-of-pocket cost modeling of adjuvant antiestrogen and radiation therapy after
lumpectomy for early-stage breast cancer across Medicaid and Medicare plans.
Int J Radiat Oncol Biol Phys. 2024 Mar 1:S0360-3016(24)00351.
J Natl Cancer Inst
- LEE CI, Elmore JG
Beyond survival: a closer look at lead-time bias and disease-free intervals in
mammography screening.
J Natl Cancer Inst. 2024;116:343-344.
- KUMAR N, Ehsan S, Banerjee S, Fernandez Perez C, et al
The unique risk factor profile of triple negative breast cancer: a comprehensive
meta-analysis.
J Natl Cancer Inst. 2024 Mar 5:djae056. doi: 10.1093.
J Pathol
- MEYER B, Stirzaker C, Ramkomuth S, Harvey K, et al
Detailed DNA methylation characterisation of phyllodes tumours identifies a
signature of malignancy and distinguishes phyllodes from metaplastic breast
carcinoma.
J Pathol. 2024;262:480-494.
Nature
- STENZINGER A, Klauschen F
Forget lung, breast or prostate cancer? Why we shouldn't abandon tumour names
yet.
Nature. 2024;627:38.
NPJ Breast Cancer
- PASCUAL T, Fernandez-Martinez A, Agrawal Y, Pfefferle AD, et al
Cell-cycle inhibition and immune microenvironment in breast cancer treated with
ribociclib and letrozole or chemotherapy.
NPJ Breast Cancer. 2024;10:20.
PLoS One
- ABDUL REHMAN M, Tahir E, Ghulam Hussain H, Khalid A, et al
Awareness regarding breast cancer amongst women in Pakistan: A systematic review
and meta-analysis.
PLoS One. 2024;19:e0298275.
- WAHLSTROM E, Audisio RA, Selvaggi G
Aspects to consider regarding breast cancer risk in trans men: A systematic
review and risk management approach.
PLoS One. 2024;19:e0299333.
- KESSLER LG, Comstock B, Aiello Bowles EJ, Mou J, et al
Protocol to measure validity and reliability of colorectal, breast, cervical and
lung cancer screening questions from the 2021 National Health Interview Survey:
Methodology and design.
PLoS One. 2024;19:e0297773.
Proc Natl Acad Sci U S A
- LAMIA KA
Telling time in tumor samples reveals diversity of clock disruption.
Proc Natl Acad Sci U S A. 2024;121:e2401496121.
- TAYLOR-PHILLIPS S, Jenkinson D, Stinton C, Kunar MA, et al
Fatigue and vigilance in medical experts detecting breast cancer.
Proc Natl Acad Sci U S A. 2024;121:e2309576121.
Radiother Oncol
- KUBECZKO M, Jarzab M, Gabrys D, Krzywon A, et al
Corrigendum to "Safety and feasibility of CDK4/6 inhibitors treatment combined
with radiotherapy in patients with HR-positive/HER2-negative breast cancer. A
systematic review and meta-analysis" [Radiother. Oncol. 187 (2023) 109839].
Radiother Oncol. 2024;194:110188.
- HOGSBJERG KW, Maae E, Nielsen MH, Stenbygaard L, et al
Benefit of respiratory gating in the Danish Breast Cancer Group partial breast
irradiation trial.
Radiother Oncol. 2024 Mar 3:110195. doi: 10.1016/j.radonc.2024.110195.
- GIMENO-MORALES M, Martinez-Monge R, Martinez-Lage A, Jablonska PA, et al
Long-term results of intraoperative multicatheter breast implant (IOMBI) for
accelerated partial breast irradiation (APBI) on early breast cancer patients.
Radiother Oncol. 2024;194:110193.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016